ETF Copies Hedgies,...
Health Care: Drugs
Progenics Pharmaceuticals Inc. (PGNX: NASDAQ)
$4.03 -0.14 | -3.36%
05/21/13 - 02:26 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -35.43M | 10.38M | -69.72M | -30.61M |
| Operating Gains/Losses | -327.00K | 0.00 | 0.00 | -237.00K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -5.42M | 767.00K | 5.24M | -6.18M |
| (Increase) Decrease in Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | -754.00K | 1.93M | 284.00K | 2.06M |
| (Decrease) Increase In Payables | -691.00K | -3.35M | 3.85M | -660.00K |
| (Decrease) Increase In Other Current Liabilities | -2.42M | 3.00K | -58.00K | -31.80M |
| (Increase) Decrease In Other Working Capital | 2.54M | 228.00K | 1.64M | -1.67M |
| Other Non-Cash Items | 6.54M | 6.36M | 9.52M | 13.32M |
| Net Cash From Continuing Operations | -34.64M | 18.39M | -46.41M | -49.81M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -34.64M | 18.39M | -46.41M | -49.81M |
| Sale of Property, Plant & Equipment | 390.00K | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 100.00K | 0.00 | 0.00 | 80.23M |
| Purchases of Property, Plant & Equipment | -767.00K | -226.00K | -2.17M | -901.00K |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 320.00K |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -277.00K | 74.00K | -471.00K | 79.65M |
| Issuance of Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 23.65M | 3.73M | 3.90M | 4.87M |
| Repayment of Long-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Cash From Financing Activities | 23.65M | 3.73M | 3.90M | 4.87M |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | -11.27M | 22.19M | -42.98M | 34.72M |
Portfolios with PGNX
- Portfolio NameUser Type
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorDrugs Facing FDA Approval i...
- UserGFNN Stockdiagnostics 14
- ContributorStocks Rising On Unusual Vo...
- ProTudor Investment
- ContributorStocks At New 52-Week Highs...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks At New 52-Week Highs...
Latest PGNX Headlines from TheStreet
- Progenics Pharmaceuticals Added To The NASDAQ Biotechnology Index 05.17.13 | 05:05 pm
- Progenics Pharmaceuticals Announces First Quarter 2013 Financial Results 05.10.13 | 07:05 am
- Progenics Pharmaceuticals To Host Conference Call To Review First Quarter 2013 Financial Results On May 10 05.06.13 | 05:05 pm
- Short Interest Moves 19% Higher For PGNX 04.25.13 | 04:04 pm
- Progenics Pharmaceuticals To Present At Needham Healthcare Conference 04.24.13 | 05:04 pm
- 'Mad Money' Lightning Round: I Like Priceline 04.02.13 | 06:04 am
- Cramer's 'Mad Money' Recap: Checking My List 04.01.13 | 07:04 pm
- Progenics Pharmaceuticals Announces Fourth Quarter And Year-End 2012 Financial Results 03.15.13 | 07:03 am
- Progenics Pharmaceuticals To Host Conference Call To Review Fourth Quarter Financial Results On March 15 03.08.13 | 03:03 pm
- 5 Stocks Under $10 Set to Soar 03.07.13 | 01:03 pm
Press Releases for PGNX
- MedImmune Announces Agreement With Progenics Pharmaceuticals To Develop Therapies Against Serious Bacterial Infections - PR Newswire 12.17.12 | 09:12 am
- Salix And Progenics Receive Complete Response Letter From FDA For RELISTOR® SNDA - Business Wire 07.27.12 | 07:07 pm
- Salix And Progenics Announce Positive Highly Statistically Significant Results Of Oral Methylnaltrexone For Phase 3 Trial In Chronic, Non-Cancer Pain Subjects With Opioid-Induced Constipation - Business Wire 12.20.11 | 07:12 am
- Progenics And Salix Announce FDA Acceptance Of SNDA Filing For RELISTOR® In Patients With Non-Cancer Pain - Business Wire 08.30.11 | 07:08 am
- Progenics Pharmaceuticals To Webcast Upcoming Presentations - Business Wire 04.04.11 | 08:04 am
- Progenics Pharmaceuticals Announces Fourth Quarter And Year-End 2010 Financial Results - Business Wire 03.15.11 | 08:03 am
- Progenics Pharmaceuticals Announces Changes In Executive Responsibilities - Business Wire 03.09.11 | 07:03 am
- Progenics Reports Positive Preliminary Data From Ongoing Phase 1 Clinical Study Of PSMA ADC - Business Wire 02.17.11 | 04:02 pm
- Salix Pharmaceuticals And Progenics Pharmaceuticals Announce Worldwide License Agreement For RELISTOR® - Business Wire 02.07.11 | 07:02 am
- Progenics Pharmaceuticals And Salix Pharmaceuticals Announce Worldwide License Agreement For RELISTOR® - Business Wire 02.07.11 | 07:02 am
Partner Headlines for PGNX
- 5 Healthcare Companies With Recent Insider Buying - Seeking Alpha 11.18.12 | 09:11 am
- 5 Stocks That Dropped the Most Since Gurus Bought Them - NASDAQ 09.13.12 | 07:09 pm
- Another Delay for Salix Candidate - Analyst Blog - NASDAQ 09.10.12 | 10:09 pm
- Another Delay for Salix Candidate - Analyst Blog - Zacks 09.10.12 | 06:09 pm
- Stock Futures Mixed; Salix, Progenics Tumble - Investor's Business Daily 07.30.12 | 09:07 am
- Positive Data on Theravance Drug - Analyst Blog - Zacks 07.11.12 | 06:07 pm
- The Zacks Analyst Blog Highlights: US Airways Group, United Continental Holdings, Delta Airlines, Salix Pharmaceuticals and Progenics Pharmaceuticals - Press Releases - Zacks 04.24.12 | 09:04 am
- What's It Going To Take To Get Salix Cheap? - Seeking Alpha 02.29.12 | 08:02 am
- Progenics Should Outperform The Market In The Short Term - Seeking Alpha 02.15.12 | 08:02 am
- Biotech Stocks To Watch In 2012 - Seeking Alpha 02.06.12 | 09:02 am
